课题基金 / 基金详情

Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans

Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
感染艾滋病毒和未感染艾滋病毒的退伍军人的心血管疾病机制
批准号:
8322045
负责人:
CHUNG-CHOU Ho CHANG
金额:
$105.71万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-25 至 2016-08-31
关键词:
AbbreviationsAbdomenAcquired Immunodeficiency SyndromeAdherenceAdipose tissueAdultAdverse eventAftercareAgeAgingAlberta provinceAlcohol abuseAlcohol consumptionAlcohol or Other Drugs useAlcoholsArbitrationAreaAtherosclerosisBiological MarkersBloodBlood BanksBlood PressureBody CompositionBody mass indexC-reactive proteinCD4 Lymphocyte CountCalciumCardiacCardiologyCardiovascular DiseasesCardiovascular systemCaringCentral obesityCholesterolClinicalClinical DataClinical TrialsCoagulation ProcessCocaineCohort StudiesComorbidityComputerized Medical RecordCongestive Heart FailureCoronary arteryCoronary heart diseaseDataData CollectionDevelopmentDiseaseDisease OutcomeDyslipidemiasEchocardiographyEducationElectrocardiogramElectron BeamElectron Beam TomographyEnrollmentEnsureEpidemiologyEtiologyEventExerciseFibrinolysisFunctional disorderFutureGeneticHIVHIV Envelope Protein gp120HealthHealth SurveysHealth behaviorHepatitis CHepatitis C virusHigh Density LipoproteinsHigh PrevalenceHumanICD-9Immunologic Deficiency SyndromesIn VitroIndividualInfectionInflammationInflammatoryInflammatory ResponseInsulin ResistanceInternational Classification of DiseasesJusticeKidney DiseasesLaboratoriesLeftLeft Ventricular Ejection FractionLeft Ventricular HypertrophyLeft ventricular structureLipidsLipoproteinsLow-Density LipoproteinsLung diseasesMeasuresMedicalMedical centerMentorsMetabolicMinorityModelingMyocardial InfarctionMyocardiumNational Heart, Lung, and Blood InstituteObservational StudyOpportunistic InfectionsOutcomeParticipantPatientsPericardial body locationPharmaceutical PreparationsPharmacy facilityPhysical FunctionPlant LeavesPlatelet aggregationPopulationPopulation ControlPositioning AttributePrevalencePreventiveProspective StudiesProtease InhibitorProteinsProtocols documentationPulmonary HypertensionRaceRadiology SpecialtyRegimenResearch PersonnelRetroviridaeReverse Transcriptase InhibitorsRiskRisk FactorsRoleSamplingSiteSmokeSmokingSmooth Muscle MyocytesStructureSubstance abuse problemTestingThromboplastinThrombosisTissuesToxic effectVasospasmVentricularVeteransViral Load resultVirusVirus DiseasesVisceralWomen&aposs HealthWorkX-Ray Computed Tomographyadjudicatealcohol use disorderantiretroviral therapyaortic valvecardiovascular disorder riskcocaine usecofactorcohortcytokinedesigndrinkingexperiencefasting glucosefitnessfollow-upimprovedinflammatory markermedication compliancemortalitynon-nucleoside reverse transcriptase inhibitorsprogramsprospectiveskillssubcutaneoussymposiumtherapy adherencetreatment planning

项目摘要

项目成果

CHUNG-CHOU Ho CHANG的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 在使用人群对照的研究中,艾滋病毒感染与心血管疾病风险增加有关 疾病(CVD)。然而,这种风险可能部分是由艾滋病毒或其治疗以外的因素解释的。 包括吸烟、酗酒、使用可卡因、丙型肝炎感染和肾脏疾病的比率较高。同样 重要的是,艾滋病毒携带者的心血管疾病的主要机制可能与未感染的人不同,因为 血脂异常突然发生--在开始联合抗逆转录病毒治疗(CART)后,由于 艾滋病毒和丙型肝炎的炎症效应,酒精的毒性效应和可卡因引起的血管痉挛。退伍军人 老龄化队列研究是一项对3227名感染艾滋病毒的退伍军人进行的持续的、多中心的前瞻性研究 3240名年龄/种族/地点与未感染HIV的对照组匹配。与国际公认的专家在 对于心血管疾病,我们建议用判定的心血管疾病终点来补充这个队列中可用的丰富临床数据, 以及心血管疾病风险的生物标志物和测量包括:血脂异常、胰岛素抵抗、 炎症、心脏结构和功能异常、身体成分改变、亚临床 动脉粥样硬化、心脏健康,以及与血栓形成和纤溶相关的改变。有了这些 丰富的数据我们将处于独特的地位来确定:1)艾滋病毒感染是否是一个独立的风险 心血管疾病终点的因素以及丙型肝炎病毒、药物使用和CART是否改变艾滋病毒之间的关联 和心血管疾病终点,2)在艾滋病毒感染者中,心血管疾病风险的生物标志物和测量方法增加 和CART不依从性,以及3)在丙型肝炎患者中心血管风险的生物标志物和测量方法增加 感染和药物使用。重要的是,我们将针对购物车一致性和竞争风险进行调整,因为 艾滋病毒感染者的死亡率要高得多。体型大,性格好,年纪大, 主要是少数族裔患者样本,纵向随访良好,丙型肝炎病毒和 物质使用,全面的药房数据,以及建立全面的电子医疗访问 记录是该应用程序的重要优势。强大的CVD专业知识,成熟的分析 和VVS团队的指导技能,以及包含有前途的新调查员的多PI计划,确保 这项建议将有效地促进我们对艾滋病毒中心血管疾病结果和机制的了解 感染和未感染的个体。
英文摘要
ABSTRACT In studies using population controls, HIV infection has been associated with increased risk of cardiovascular disease (CVD). However, this risk may be partially explained by factors other than HIV or its treatment including higher rates of smoking, alcohol abuse, cocaine use, hepatitis C infection and renal disease. Equally important, major mechanisms of CVD among those with HIV likely differ from those without infection because lipid abnormalities occur abruptly--after initiation of combination antiretroviral therapy (CART), and because of inflammatory effects of HIV and HCV, toxic effects of alcohol and vasospasm due to cocaine. The Veterans Aging Cohort Study (VACS) is an ongoing, multicenter, prospective study of 3227 veterans with HIV infection and 3240 age/race/site matched HIV uninfected controls. Teamed with internationally recogized experts in CVD, we propose to supplement the rich clinical data available in this cohort with adjudicated CVD endpoints, and biomarkers and measures of CVD risk including: dyslipidemia, insulin resistance , markers of inflammation, cardiac structural and functional abnormalities, body composition changes, subclinical atherosclerosis, cardiac fitness, and alterations associated with thrombogenesis and fibrinolysis. With these enriched data we will be uniquely positioned to determine whether: 1) HIV infection is an independent risk factor for CVD endpoints and whether HCV, substance use and CART modify the association between HIV and CVD endpoints, 2) biomarkers and measures of CVD risk are increased among those with HIV infection and CART nonadherence, and 3) biomarkers and measures of CVD risk are increased among those with HCV infection and substance use. Importantly, we will adjust for both CART adherence and competing risk, since HIV infected individuals have a substantially higher mortality rate. The large, well characterized, older, predominantly minority patient sample with excellent longitudinal follow up and high prevalence of HCV and substance use, comprehensive pharmacy data, and established access to comprehensive electronic medical records are important leveraged strengths of this application. The strong CVD expertise, established analytic and mentoring skills of the VACS team, and a multi-PI plan incorporating a promising new investigator ensure that this proposal will effectively advance our understanding of CVD outcomes and mechanisms among HIV infected and uninfected individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Generalized Model for Post-transplant Survival
A Generalized Model for Post-transplant Survival
A Generalized Model for Post-transplant Survival
A Generalized Model for Post-transplant Survival
海外基金